3ASM's Annual Meeting on Infections Diseases, 39th Interscience Conference on Antimicrobial Agents and-Chemotherapy, Moscone Center San Franciso, California USA, 1999, 26 - 29.
4National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990 may 1999, issue june 1999 [J]. AmJ Infect Control, 1999, 27 : 520 - 532.
5Casterton JW, Veeh R, Shirtliff M, et al. The applicati on of biofilm science to the study and control of chronic infections[J]. J Clin Invest, 2003, 112: 1466-1477.
6Petersen FC, Pecharki D, Scheie AA. Biofdm mode of growth of streptococcus intermedius favored by a competence - stimulating signaling peptide [J]. J Bacterial, 2004, 186: 6327-6331.
7Lamfon H, Porter SR, McCullough M, et al. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor To chlorhexidine, fluconazole and miconazole : a.longitudinal study [ J ]. J Antimicrob Chemother, 2004, 53:383-385.
8Valles J, Artigas A, Rello J. Continuous aspiration of subglottic secretions in preventing ventilator associated pneumonia [J].Ann Intern Med, 1995, 122: 179.
9Manangan LP, Banerjec SN, Jarvis WR. Association between implementation of CDC recommendations and ventilato - associated pneumonia at selected us hospitals [J]. Am J Infect Control, 2000, 28:222 - 227.
10Cunha BA, Nosocomial pneumonia. Diagnostic and therapeutic considerations [J]. Med Clin North Am, 2001, 85 (1) : 79 -114.
